Annual CFF
-$47.78 M
+$29.36 M+38.05%
31 December 2023
Summary:
Fulgent Genetics annual cash flow from financing activities is currently -$47.78 million, with the most recent change of +$29.36 million (+38.05%) on 31 December 2023. During the last 3 years, it has fallen by -$309.04 million (-118.29%). FLGT annual CFF is now -118.29% below its all-time high of $261.25 million, reached on 31 December 2020.FLGT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$567.00 K
+$579.00 K+50.52%
30 September 2024
Summary:
Fulgent Genetics quarterly cash flow from financing activities is currently -$567.00 thousand, with the most recent change of +$579.00 thousand (+50.52%) on 30 September 2024. Over the past year, it has increased by +$3.91 million (+87.33%). FLGT quarterly CFF is now -100.26% below its all-time high of $218.90 million, reached on 31 December 2020.FLGT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$30.47 M
+$3.91 M+11.36%
30 September 2024
Summary:
Fulgent Genetics TTM cash flow from financing activities is currently -$30.47 million, with the most recent change of +$3.91 million (+11.36%) on 30 September 2024. Over the past year, it has increased by +$20.96 million (+40.75%). FLGT TTM CFF is now -109.05% below its all-time high of $336.71 million, reached on 30 June 2021.FLGT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FLGT Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.0% | +87.3% | +40.8% |
| 3 y3 years | -118.3% | +81.0% | -110.5% |
| 5 y5 years | -10000.0% | -150.3% | -2770.6% |
FLGT Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -118.3% | +38.0% | -104.3% | +98.4% | -110.5% | +63.0% |
| 5 y | 5 years | -118.3% | +38.0% | -100.3% | +98.4% | -109.0% | +63.0% |
| alltime | all time | -118.3% | +38.0% | -100.3% | +98.4% | -109.0% | +63.0% |
Fulgent Genetics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$567.00 K(-50.5%) | -$30.47 M(-11.4%) |
| June 2024 | - | -$1.15 M(-59.2%) | -$34.38 M(-30.5%) |
| Mar 2024 | - | -$2.81 M(-89.2%) | -$49.49 M(+3.6%) |
| Dec 2023 | -$47.78 M(-38.1%) | -$25.95 M(+480.0%) | -$47.78 M(-7.1%) |
| Sept 2023 | - | -$4.47 M(-72.5%) | -$51.43 M(-37.6%) |
| June 2023 | - | -$16.26 M(+1376.7%) | -$82.42 M(+6.6%) |
| Mar 2023 | - | -$1.10 M(-96.3%) | -$77.31 M(+0.2%) |
| Dec 2022 | -$77.14 M(-190.3%) | -$29.59 M(-16.6%) | -$77.14 M(+124.3%) |
| Sept 2022 | - | -$35.46 M(+218.0%) | -$34.39 M(+1690.4%) |
| June 2022 | - | -$11.15 M(+1094.0%) | -$1.92 M(-105.2%) |
| Mar 2022 | - | -$934.00 K(-107.1%) | $37.12 M(-56.5%) |
| Dec 2021 | $85.41 M(-67.3%) | $13.15 M(-540.1%) | $85.41 M(-70.7%) |
| Sept 2021 | - | -$2.99 M(-110.7%) | $291.15 M(-13.5%) |
| June 2021 | - | $27.89 M(-41.1%) | $336.71 M(+9.1%) |
| Mar 2021 | - | $47.35 M(-78.4%) | $308.76 M(+18.2%) |
| Dec 2020 | $261.25 M | $218.90 M(+414.2%) | $261.25 M(+273.3%) |
| Sept 2020 | - | $42.57 M(<-9900.0%) | $69.99 M(+145.2%) |
| June 2020 | - | -$59.00 K(-64.0%) | $28.54 M(-0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$164.00 K(-100.6%) | $28.61 M(-0.6%) |
| Dec 2019 | $28.77 M(>+9900.0%) | $27.64 M(+2352.4%) | $28.77 M(+2421.9%) |
| Sept 2019 | - | $1.13 M(>+9900.0%) | $1.14 M(+7506.7%) |
| June 2019 | - | $5000.00(+25.0%) | $15.00 K(-11.8%) |
| Mar 2019 | - | $4000.00(-20.0%) | $17.00 K(+13.3%) |
| Dec 2018 | $15.00 K(-101.9%) | $5000.00(+400.0%) | $15.00 K(+7.1%) |
| Sept 2018 | - | $1000.00(-85.7%) | $14.00 K(-17.6%) |
| June 2018 | - | $7000.00(+250.0%) | $17.00 K(-48.5%) |
| Mar 2018 | - | $2000.00(-50.0%) | $33.00 K(-104.3%) |
| Dec 2017 | -$770.00 K(-101.7%) | $4000.00(0.0%) | -$770.00 K(-102.1%) |
| Sept 2017 | - | $4000.00(-82.6%) | $37.08 M(+18.7%) |
| June 2017 | - | $23.00 K(-102.9%) | $31.24 M(-30.6%) |
| Mar 2017 | - | -$801.00 K(-102.1%) | $44.99 M(-1.7%) |
| Dec 2016 | $45.79 M(+1208.3%) | $37.85 M(-748.5%) | $45.79 M(+477.1%) |
| Sept 2016 | - | -$5.84 M(-142.4%) | $7.93 M(-42.4%) |
| June 2016 | - | $13.77 M(>+9900.0%) | $13.77 M(>+9900.0%) |
| Mar 2016 | - | $0.00 | $0.00 |
| Dec 2015 | $3.50 M(-12.5%) | - | - |
| Dec 2014 | $4.00 M | - | - |
FAQ
- What is Fulgent Genetics annual cash flow from financing activities?
- What is the all time high annual CFF for Fulgent Genetics?
- What is Fulgent Genetics annual CFF year-on-year change?
- What is Fulgent Genetics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Fulgent Genetics?
- What is Fulgent Genetics quarterly CFF year-on-year change?
- What is Fulgent Genetics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Fulgent Genetics?
- What is Fulgent Genetics TTM CFF year-on-year change?
What is Fulgent Genetics annual cash flow from financing activities?
The current annual CFF of FLGT is -$47.78 M
What is the all time high annual CFF for Fulgent Genetics?
Fulgent Genetics all-time high annual cash flow from financing activities is $261.25 M
What is Fulgent Genetics annual CFF year-on-year change?
Over the past year, FLGT annual cash flow from financing activities has changed by +$29.36 M (+38.05%)
What is Fulgent Genetics quarterly cash flow from financing activities?
The current quarterly CFF of FLGT is -$567.00 K
What is the all time high quarterly CFF for Fulgent Genetics?
Fulgent Genetics all-time high quarterly cash flow from financing activities is $218.90 M
What is Fulgent Genetics quarterly CFF year-on-year change?
Over the past year, FLGT quarterly cash flow from financing activities has changed by +$3.91 M (+87.33%)
What is Fulgent Genetics TTM cash flow from financing activities?
The current TTM CFF of FLGT is -$30.47 M
What is the all time high TTM CFF for Fulgent Genetics?
Fulgent Genetics all-time high TTM cash flow from financing activities is $336.71 M
What is Fulgent Genetics TTM CFF year-on-year change?
Over the past year, FLGT TTM cash flow from financing activities has changed by +$20.96 M (+40.75%)